With a focus on improving access and modernizing surgical techniques, this episode covers how the hepatic artery infusion (HAI) pump is transforming the landscape for patients with liver-directed malignancies in Kentucky.

Host Dr. Zach Pulliam, Medical Oncology Fellow at University of Louisville, speaks with expert Dr. Michael Cavnar from the University of Kentucky Markey Cancer Center to discuss the history, clinical benefits, and new accessibility trials for HAI pump therapy.

The conversation focuses on the logistics of rural cancer care, survival benefits for colorectal liver metastases and cholangiocarcinoma, and the future of home-based chemotherapy infusion.

Host: Zach Pulliam, MD,

Guest: Michael Cavnar, MD

The Kentucky Society of Clinical Oncology (KYSCO)

blawrence@kysco-oncology.org

This episode explores the latest advancements in hepatic arterial infusion (HAI) pump therapy and its impact on cancer care in Kentucky. Surgical Oncologist Brent Xia, MD of the St. Elizabeth Cancer Center, discusses the multidisciplinary effort required to implement this technology and its role in providing targeted, high-dose chemotherapy for liver-directed

The conversation highlights the survival benefits of regional therapy, the importance of multidisciplinary tumor boards, and new ways to reduce financial toxicity for patients.

Host: Andrew Hearn, MD, Hematology & Oncology Fellow, University of Louisville

Guest: Brent Xia MD Surgical Oncologist, St. Elizabeth Healthcare / The Yung Family Cancer Center

The Kentucky Society of Clinical Oncology (KYSCO)

https://www.interaoncology.com/patients-caregivers/find-an-hai-center

blawrence@kysco-oncology.org

With a focus on improving access and managing toxicity, this episode covers how new therapies are transforming the landscape for small cell lung cancer patients across the state.

Host Dr. Shreyas Kalantri, Hematology and Oncology Chief Fellow at University of Louisville, speaks with experts Dr. Goetz Kloecker and Dr. Firas Badin to discuss groundbreaking trials and treatment advances for small cell lung cancer like the IMforte and DeLLphi-304 studies. The conversation focuses on real-world implications, survival benefits, and the future of cancer care in Kentucky.

Host: Dr. Shreyas Kalantri

Guest: Dr. Goetz Kloecker

Guest: Dr. Firas Badin

The Kentucky Society of Clinical Oncology (KYSCO)

Email: blawrence@accc-cancer.org

In the latest episode of KYSCO Oncology Voices, host Dr. Shreyas Kalantri, Hematology and Oncology Chief Fellow at University of Louisville, shares updates on recent advances in non-small cell lung cancer (NSCLC) with renowned experts Dr. Goetz Kloecker and Dr. Firas Badin.

They cover landmark trials such as CheckMate 816 (neoadjuvant immunotherapy) and NeoADAURA (neoadjuvant targeted therapy for EGFR-mutant NSCLC), discussing their implications on practice and the multidisciplinary approach to lung cancer care in Kentucky. With Kentucky having one of the highest lung cancer incidence rates, this episode ​focuses on how recent trial findings can shape patient outcomes in ​our state.

Tune in to explore how cutting-edge research is being translated into real-world clinical practices.

Host: Dr. Shreyas Kalantri

Guest: Dr. Goetz Kloecker

Guest: Dr. Firas Badin

The Kentucky Society of Clinical Oncology (KYSCO)

Email: blawrence@accc-cancer.org

Are you up-to-date with the latest breast cancer advances? In the latest episode of KYSCO Oncology Voices, host Dr. Matthew Kurian discusses key breast cancer updates from ASCO 2025 with guest experts Dr. Brian Dong and Dr. Ruta Arays.

They explore trial results, including SERENA-6 and ASCENT-04, and their potential implications for treatment decisions in Kentucky. Tune in to understand how these updates might impact both academic and community settings, focusing on the specific challenges faced in Kentucky.

Host: Dr. Matt Kurian

Guest: Dr. Ruta Arays

Guest: Dr. Brian Dong

The Kentucky Society of Clinical Oncology (KYSCO)

Email: blawrence@accc-cancer.org

Kentucky is working to reduce disparities and improve early cancer detection. In the inaugural episode of the Kentucky Society of Clinical Oncology (KYSCO) Podcast, host Dr. Matt Kurian talks with experts Mollie Beck, Oncology Pharmacist, and Jordan Brady, Coordinator of Clinical Genetics, about everything from local statistics to genetic screenings and treatments. Listen to learn about the importance of early detection, legislative changes, and the benefits of both germline and somatic testing.

Host: Matthew Kurian, MD
Guest: Mollie Beck, PharmD, BCOP
Guest: Jordan Brady, MS, CGC
The Kentucky Society of Clinical Oncology (KYSCO)